Biological Correlates of Abuse in Women with Premenstrual Dysphoric Disorder and Healthy Controls
Susan S. Girdler, PhD,
Andrew Sherwood, PhD,
Alan L. Hinderliter, MD,
Jane Leserman, PhD,
Nancy L. Costello, PhD,
Patricia A. Straneva, PhD,
Cort A. Pedersen, MD and
Kathleen C. Light, PhD
From the Departments of Psychiatry (S.S.G., J.L., P.A.S., C.A.P., K.C.L.), Cardiology (A.L.H.), and Dentistry (N.L.C.), University of North Carolina at Chapel Hill and Psychiatry (A.S.), Duke University Medical Center, Durham, North Carolina.

View larger version (21K):
[in a new window]
|
Fig. 1. Change in plasma norepinephrine during stressors in controls (top panel) and PMDD women (bottom panel) as a function of abuse histories and menstrual cycle phase.
|
|

View larger version (20K):
[in a new window]
|
Fig. 2. Change in plasma cortisol during stress in controls (top panel) and PMDD women (bottom panel) as a function of abuse histories and menstrual cycle phase.
|
|

View larger version (29K):
[in a new window]
|
Fig. 3. Change in cardiac output during stressors in controls (top panel) and PMDD women (bottom panel) as a function of abuse histories and menstrual cycle phase.
|
|
Copyright © 2003 by the American Psychosomatic Society